LivaNova (LIVN) Change in Receivables (2015 - 2026)
LivaNova's (LIVN) quarterly Change in Receivables came in at $2.5 million in Q2 2026, down 74.59% year-over-year from $9.8 million in Q2 2025, and down 83.07% quarter-over-quarter from $14.7 million in Q1 2026.
Analysis
LivaNova (LIVN) Change in Receivables (2015 - 2026) Analysis & Trends
LivaNova has disclosed Change in Receivables across 12 years of filings, most recently posting $2.5 million for Q2 2026.
- In Q2 2026, Change in Receivables fell 74.59% year-over-year to $2.5 million; the TTM figure through Jun 2026 stood at $14.2 million (up 28.85% YoY), while the FY2025 annual figure was $10.7 million, up 196.79% from the prior year.
- Change in Receivables came in at $2.5 million for Q2 2026 at LivaNova, down from $14.7 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $20.6 million in Q4 2023 to a low of -$9.0 million in Q3 2024.
- Average Change in Receivables over 5 years is $2.8 million, with a median of $2.8 million recorded in 2022.
- The largest YoY upside for Change in Receivables was 853.42% in 2023 against a maximum downside of 405.89% in 2023.
- Over 5 years, Change in Receivables stood at $3.1 million in 2022, then soared by 555.8% to $20.6 million in 2023, then sank by 69.14% to $6.4 million in 2024, then decreased by 23.41% to $4.9 million in 2025, then plunged by 49.05% to $2.5 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $2.5 million in Q2 2026, $14.7 million in Q1 2026, and $4.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -90.00 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 2.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.48 Mn |
| Mar 31, 2026 | 14.67 Mn |
| Dec 31, 2025 | 4.88 Mn |
| Sep 30, 2025 | -7.84 Mn |
| Jun 30, 2025 | 9.78 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Dec 31, 2024 | 6.37 Mn |
| Sep 30, 2024 | -9.03 Mn |
| Jun 30, 2024 | -6.41 Mn |
| Mar 31, 2024 | -1.99 Mn |
| Dec 31, 2023 | 20.63 Mn |
| Sep 30, 2023 | 7.53 Mn |
| Jun 30, 2023 | 8.27 Mn |
| Mar 31, 2023 | -7.56 Mn |
| Dec 31, 2022 | 3.15 Mn |
| Sep 30, 2022 | 790,000.00 |
| Jun 30, 2022 | 2.37 Mn |
| Mar 31, 2022 | -1.49 Mn |
| Dec 31, 2021 | 7.89 Mn |
| Sep 30, 2021 | 3.19 Mn |